أعرض في EDS

Stage IV EGFR Mutation-Negative and ALK Mutation-Negative Lung Adenocarcinoma: Long-Term Survival is Possible

التفاصيل البيبلوغرافية
العنوان: Stage IV EGFR Mutation-Negative and ALK Mutation-Negative Lung Adenocarcinoma: Long-Term Survival is Possible
المؤلفون: Shiksha Kedia, Gwenalyn Garcia, Meekoo Dhar
المصدر: Cureus
بيانات النشر: Cureus, Inc., 2015.
سنة النشر: 2015
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Mutation, Lung, biology, business.industry, General Engineering, Exceptional Response, stage iv lung cancer, medicine.disease, medicine.disease_cause, lung cancer, medicine.anatomical_structure, Internal medicine, medicine, biology.protein, Adenocarcinoma of the lung, Adenocarcinoma, Anaplastic lymphoma kinase, Epidermal growth factor receptor, Lung cancer, business, long-term survival
الوصف: Lung cancer is the leading cause of cancer death in the United States with a five-year survival of 16.8% for all stages and median survival of four months for Stage IV disease. We report a case of a 54-year-old male with a seven-year survival after being diagnosed with Stage IV epidermal growth factor receptor (EGFR) mutation-negative and anaplastic lymphoma kinase (ALK) mutation-negative adenocarcinoma of the lung, demonstrating an exceptional response to treatment.
تدمد: 2168-8184
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51c1e8410f91048e41fbf149131c1bd5
https://doi.org/10.7759/cureus.419
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....51c1e8410f91048e41fbf149131c1bd5
قاعدة البيانات: OpenAIRE
الوصف
تدمد:21688184